nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—SLC22A3—Melphalan—ovarian cancer	0.213	0.34	CbGbCtD
Cimetidine—ABCB1—ovarian cancer	0.168	1	CbGaD
Cimetidine—ABCB11—Paclitaxel—ovarian cancer	0.0673	0.107	CbGbCtD
Cimetidine—SLC22A7—Docetaxel—ovarian cancer	0.044	0.07	CbGbCtD
Cimetidine—ABCB11—Doxorubicin—ovarian cancer	0.0363	0.0577	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0236	0.0376	CbGbCtD
Cimetidine—CYP3A7—Paclitaxel—ovarian cancer	0.0236	0.0376	CbGbCtD
Cimetidine—ABCB1—Topotecan—ovarian cancer	0.0233	0.0371	CbGbCtD
Cimetidine—CYP3A5—Paclitaxel—ovarian cancer	0.0177	0.0282	CbGbCtD
Cimetidine—CYP3A7—Docetaxel—ovarian cancer	0.0171	0.0272	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0171	0.0272	CbGbCtD
Cimetidine—CYP2C8—Paclitaxel—ovarian cancer	0.017	0.0271	CbGbCtD
Cimetidine—ABCB1—Vinorelbine—ovarian cancer	0.0164	0.0261	CbGbCtD
Cimetidine—CYP2D6—Vinorelbine—ovarian cancer	0.0155	0.0246	CbGbCtD
Cimetidine—CYP3A4—Topotecan—ovarian cancer	0.014	0.0222	CbGbCtD
Cimetidine—CYP3A5—Docetaxel—ovarian cancer	0.0128	0.0204	CbGbCtD
Cimetidine—CYP2C9—Paclitaxel—ovarian cancer	0.0119	0.0189	CbGbCtD
Cimetidine—ABCB1—Paclitaxel—ovarian cancer	0.0115	0.0184	CbGbCtD
Cimetidine—CYP3A4—Vinorelbine—ovarian cancer	0.00984	0.0157	CbGbCtD
Cimetidine—ABCB1—Docetaxel—ovarian cancer	0.00834	0.0133	CbGbCtD
Cimetidine—CYP3A4—Paclitaxel—ovarian cancer	0.00691	0.011	CbGbCtD
Cimetidine—ABCB1—Doxorubicin—ovarian cancer	0.00622	0.00989	CbGbCtD
Cimetidine—CYP2D6—Doxorubicin—ovarian cancer	0.00586	0.00932	CbGbCtD
Cimetidine—CYP3A4—Docetaxel—ovarian cancer	0.005	0.00795	CbGbCtD
Cimetidine—CYP3A4—Doxorubicin—ovarian cancer	0.00373	0.00593	CbGbCtD
Cimetidine—FMO1—uterine cervix—ovarian cancer	0.00166	0.037	CbGeAlD
Cimetidine—FMO1—endometrium—ovarian cancer	0.0015	0.0335	CbGeAlD
Cimetidine—SLC47A1—myometrium—ovarian cancer	0.00127	0.0282	CbGeAlD
Cimetidine—FMO1—female gonad—ovarian cancer	0.00113	0.0252	CbGeAlD
Cimetidine—FMO1—vagina—ovarian cancer	0.00112	0.0251	CbGeAlD
Cimetidine—SLC22A4—myometrium—ovarian cancer	0.00111	0.0248	CbGeAlD
Cimetidine—SLC22A3—myometrium—ovarian cancer	0.00101	0.0225	CbGeAlD
Cimetidine—SLC22A11—female reproductive system—ovarian cancer	0.001	0.0224	CbGeAlD
Cimetidine—SLC47A1—uterine cervix—ovarian cancer	0.000985	0.022	CbGeAlD
Cimetidine—FMO3—vagina—ovarian cancer	0.000972	0.0217	CbGeAlD
Cimetidine—SLC22A3—embryo—ovarian cancer	0.000971	0.0217	CbGeAlD
Cimetidine—SLC47A1—decidua—ovarian cancer	0.000939	0.0209	CbGeAlD
Cimetidine—SLC47A1—endometrium—ovarian cancer	0.000891	0.0199	CbGeAlD
Cimetidine—ABCB11—testis—ovarian cancer	0.000877	0.0196	CbGeAlD
Cimetidine—FMO3—testis—ovarian cancer	0.000867	0.0193	CbGeAlD
Cimetidine—SLC47A1—gonad—ovarian cancer	0.000827	0.0184	CbGeAlD
Cimetidine—SLC22A4—decidua—ovarian cancer	0.000823	0.0184	CbGeAlD
Cimetidine—SLC47A1—uterus—ovarian cancer	0.000821	0.0183	CbGeAlD
Cimetidine—SLC22A7—testis—ovarian cancer	0.000791	0.0176	CbGeAlD
Cimetidine—SLC22A3—uterine cervix—ovarian cancer	0.000786	0.0175	CbGeAlD
Cimetidine—SLC22A4—endometrium—ovarian cancer	0.000781	0.0174	CbGeAlD
Cimetidine—SLC47A1—female reproductive system—ovarian cancer	0.000738	0.0165	CbGeAlD
Cimetidine—SLC22A5—myometrium—ovarian cancer	0.000734	0.0164	CbGeAlD
Cimetidine—FMO1—lymph node—ovarian cancer	0.000727	0.0162	CbGeAlD
Cimetidine—Neutropenia—Melphalan—ovarian cancer	0.000724	0.00581	CcSEcCtD
Cimetidine—SLC22A3—endometrium—ovarian cancer	0.000711	0.0159	CbGeAlD
Cimetidine—Pneumonia—Topotecan—ovarian cancer	0.000709	0.00569	CcSEcCtD
Cimetidine—Hallucination—Chlorambucil—ovarian cancer	0.000707	0.00568	CcSEcCtD
Cimetidine—Erythema multiforme—Chlorambucil—ovarian cancer	0.000672	0.0054	CcSEcCtD
Cimetidine—SLC47A1—female gonad—ovarian cancer	0.000672	0.015	CbGeAlD
Cimetidine—SLC47A1—vagina—ovarian cancer	0.000668	0.0149	CbGeAlD
Cimetidine—Pancreatitis—Vinorelbine—ovarian cancer	0.000663	0.00533	CcSEcCtD
Cimetidine—SLC22A3—gonad—ovarian cancer	0.000659	0.0147	CbGeAlD
Cimetidine—SLC22A4—female reproductive system—ovarian cancer	0.000647	0.0144	CbGeAlD
Cimetidine—Pancytopenia—Vinorelbine—ovarian cancer	0.000642	0.00516	CcSEcCtD
Cimetidine—Neutropenia—Vinorelbine—ovarian cancer	0.000632	0.00508	CcSEcCtD
Cimetidine—FMO3—lymph node—ovarian cancer	0.000628	0.014	CbGeAlD
Cimetidine—Alopecia—Chlorambucil—ovarian cancer	0.000628	0.00504	CcSEcCtD
Cimetidine—Hepatitis—Melphalan—ovarian cancer	0.00062	0.00498	CcSEcCtD
Cimetidine—Bone marrow depression—Epirubicin—ovarian cancer	0.000614	0.00493	CcSEcCtD
Cimetidine—SLC22A4—bone marrow—ovarian cancer	0.000611	0.0136	CbGeAlD
Cimetidine—Pneumonia—Vinorelbine—ovarian cancer	0.000607	0.00487	CcSEcCtD
Cimetidine—SLC47A1—testis—ovarian cancer	0.000596	0.0133	CbGeAlD
Cimetidine—SLC22A3—female reproductive system—ovarian cancer	0.000589	0.0131	CbGeAlD
Cimetidine—SLC22A4—vagina—ovarian cancer	0.000585	0.0131	CbGeAlD
Cimetidine—SLC22A5—uterine cervix—ovarian cancer	0.000571	0.0127	CbGeAlD
Cimetidine—Agitation—Chlorambucil—ovarian cancer	0.000569	0.00457	CcSEcCtD
Cimetidine—Bone marrow depression—Doxorubicin—ovarian cancer	0.000568	0.00456	CcSEcCtD
Cimetidine—Agranulocytosis—Vinorelbine—ovarian cancer	0.000563	0.00452	CcSEcCtD
Cimetidine—HRH2—lymph node—ovarian cancer	0.000559	0.0125	CbGeAlD
Cimetidine—Alopecia—Topotecan—ovarian cancer	0.000559	0.00449	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.000558	0.00448	CcSEcCtD
Cimetidine—SLC22A1—vagina—ovarian cancer	0.000557	0.0124	CbGeAlD
Cimetidine—Leukopenia—Chlorambucil—ovarian cancer	0.000554	0.00445	CcSEcCtD
Cimetidine—Renal impairment—Paclitaxel—ovarian cancer	0.000553	0.00444	CcSEcCtD
Cimetidine—Alopecia—Melphalan—ovarian cancer	0.000548	0.0044	CcSEcCtD
Cimetidine—SLC22A3—female gonad—ovarian cancer	0.000536	0.012	CbGeAlD
Cimetidine—SLC22A3—vagina—ovarian cancer	0.000532	0.0119	CbGeAlD
Cimetidine—SLC22A5—endometrium—ovarian cancer	0.000517	0.0115	CbGeAlD
Cimetidine—Confusional state—Chlorambucil—ovarian cancer	0.000509	0.00409	CcSEcCtD
Cimetidine—CYP2C8—endometrium—ovarian cancer	0.0005	0.0112	CbGeAlD
Cimetidine—CYP3A5—uterine cervix—ovarian cancer	0.000499	0.0111	CbGeAlD
Cimetidine—Malaise—Topotecan—ovarian cancer	0.000497	0.00399	CcSEcCtD
Cimetidine—Hepatic failure—Docetaxel—ovarian cancer	0.000496	0.00399	CcSEcCtD
Cimetidine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000494	0.00397	CcSEcCtD
Cimetidine—Leukopenia—Topotecan—ovarian cancer	0.000493	0.00396	CcSEcCtD
Cimetidine—Blood creatinine increased—Paclitaxel—ovarian cancer	0.000493	0.00396	CcSEcCtD
Cimetidine—Liver injury—Epirubicin—ovarian cancer	0.000493	0.00396	CcSEcCtD
Cimetidine—Leukopenia—Melphalan—ovarian cancer	0.000483	0.00388	CcSEcCtD
Cimetidine—Alopecia—Vinorelbine—ovarian cancer	0.000478	0.00384	CcSEcCtD
Cimetidine—SLC22A3—testis—ovarian cancer	0.000475	0.0106	CbGeAlD
Cimetidine—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000474	0.00381	CcSEcCtD
Cimetidine—Arthralgia—Topotecan—ovarian cancer	0.000469	0.00377	CcSEcCtD
Cimetidine—Myalgia—Topotecan—ovarian cancer	0.000469	0.00377	CcSEcCtD
Cimetidine—Renal impairment—Docetaxel—ovarian cancer	0.000469	0.00376	CcSEcCtD
Cimetidine—Myalgia—Melphalan—ovarian cancer	0.000459	0.00369	CcSEcCtD
Cimetidine—Liver injury—Doxorubicin—ovarian cancer	0.000456	0.00366	CcSEcCtD
Cimetidine—Anaphylactic shock—Topotecan—ovarian cancer	0.00045	0.00361	CcSEcCtD
Cimetidine—Pancreatitis—Paclitaxel—ovarian cancer	0.000446	0.00358	CcSEcCtD
Cimetidine—Anaphylactic shock—Melphalan—ovarian cancer	0.00044	0.00354	CcSEcCtD
Cimetidine—Thrombocytopenia—Topotecan—ovarian cancer	0.00044	0.00354	CcSEcCtD
Cimetidine—Fatigue—Chlorambucil—ovarian cancer	0.000435	0.0035	CcSEcCtD
Cimetidine—Pancytopenia—Paclitaxel—ovarian cancer	0.000432	0.00347	CcSEcCtD
Cimetidine—SLC47A1—lymph node—ovarian cancer	0.000432	0.00963	CbGeAlD
Cimetidine—Thrombocytopenia—Melphalan—ovarian cancer	0.000431	0.00346	CcSEcCtD
Cimetidine—Tachycardia—Melphalan—ovarian cancer	0.00043	0.00345	CcSEcCtD
Cimetidine—CYP2C19—vagina—ovarian cancer	0.000429	0.00958	CbGeAlD
Cimetidine—SLC22A5—female reproductive system—ovarian cancer	0.000428	0.00955	CbGeAlD
Cimetidine—Atrioventricular block—Epirubicin—ovarian cancer	0.000427	0.00343	CcSEcCtD
Cimetidine—Neutropenia—Paclitaxel—ovarian cancer	0.000425	0.00342	CcSEcCtD
Cimetidine—Malaise—Vinorelbine—ovarian cancer	0.000425	0.00341	CcSEcCtD
Cimetidine—Leukopenia—Vinorelbine—ovarian cancer	0.000422	0.00339	CcSEcCtD
Cimetidine—Musculoskeletal pain—Epirubicin—ovarian cancer	0.00042	0.00337	CcSEcCtD
Cimetidine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000416	0.00334	CcSEcCtD
Cimetidine—CYP2C8—female reproductive system—ovarian cancer	0.000414	0.00924	CbGeAlD
Cimetidine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00041	0.00329	CcSEcCtD
Cimetidine—Pneumonia—Paclitaxel—ovarian cancer	0.000408	0.00328	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000402	0.00323	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.000402	0.00323	CcSEcCtD
Cimetidine—Myalgia—Vinorelbine—ovarian cancer	0.000401	0.00322	CcSEcCtD
Cimetidine—Arthralgia—Vinorelbine—ovarian cancer	0.000401	0.00322	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000401	0.00322	CcSEcCtD
Cimetidine—Body temperature increased—Chlorambucil—ovarian cancer	0.000399	0.00321	CcSEcCtD
Cimetidine—Renal failure—Paclitaxel—ovarian cancer	0.000399	0.0032	CcSEcCtD
Cimetidine—Atrioventricular block—Doxorubicin—ovarian cancer	0.000395	0.00318	CcSEcCtD
Cimetidine—SLC22A5—female gonad—ovarian cancer	0.000389	0.00869	CbGeAlD
Cimetidine—Aplastic anaemia—Epirubicin—ovarian cancer	0.000389	0.00313	CcSEcCtD
Cimetidine—Musculoskeletal pain—Doxorubicin—ovarian cancer	0.000388	0.00312	CcSEcCtD
Cimetidine—Fatigue—Topotecan—ovarian cancer	0.000388	0.00311	CcSEcCtD
Cimetidine—SLC22A5—vagina—ovarian cancer	0.000387	0.00864	CbGeAlD
Cimetidine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000385	0.00309	CcSEcCtD
Cimetidine—Constipation—Topotecan—ovarian cancer	0.000384	0.00309	CcSEcCtD
Cimetidine—Fatigue—Melphalan—ovarian cancer	0.00038	0.00305	CcSEcCtD
Cimetidine—SLC22A4—lymph node—ovarian cancer	0.000378	0.00844	CbGeAlD
Cimetidine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000377	0.00302	CcSEcCtD
Cimetidine—Tachycardia—Vinorelbine—ovarian cancer	0.000375	0.00301	CcSEcCtD
Cimetidine—CYP2C8—vagina—ovarian cancer	0.000375	0.00836	CbGeAlD
Cimetidine—Hypersensitivity—Chlorambucil—ovarian cancer	0.000372	0.00299	CcSEcCtD
Cimetidine—Bradycardia—Paclitaxel—ovarian cancer	0.000371	0.00298	CcSEcCtD
Cimetidine—Feeling abnormal—Topotecan—ovarian cancer	0.00037	0.00298	CcSEcCtD
Cimetidine—CYP2C9—female reproductive system—ovarian cancer	0.000368	0.00821	CbGeAlD
Cimetidine—Pancytopenia—Docetaxel—ovarian cancer	0.000366	0.00294	CcSEcCtD
Cimetidine—Asthenia—Chlorambucil—ovarian cancer	0.000362	0.00291	CcSEcCtD
Cimetidine—Neutropenia—Docetaxel—ovarian cancer	0.000361	0.0029	CcSEcCtD
Cimetidine—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00036	0.00289	CcSEcCtD
Cimetidine—Body temperature increased—Topotecan—ovarian cancer	0.000355	0.00285	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00035	0.00281	CcSEcCtD
Cimetidine—CYP2E1—female reproductive system—ovarian cancer	0.000349	0.00778	CbGeAlD
Cimetidine—Pneumonia—Docetaxel—ovarian cancer	0.000346	0.00278	CcSEcCtD
Cimetidine—Diarrhoea—Chlorambucil—ovarian cancer	0.000346	0.00278	CcSEcCtD
Cimetidine—SLC22A5—testis—ovarian cancer	0.000345	0.00771	CbGeAlD
Cimetidine—SLC22A3—lymph node—ovarian cancer	0.000344	0.00768	CbGeAlD
Cimetidine—Erythema multiforme—Paclitaxel—ovarian cancer	0.000344	0.00276	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000341	0.00274	CcSEcCtD
Cimetidine—ABCB1—myometrium—ovarian cancer	0.000341	0.0076	CbGeAlD
Cimetidine—CYP3A5—female gonad—ovarian cancer	0.00034	0.00759	CbGeAlD
Cimetidine—CYP3A5—vagina—ovarian cancer	0.000338	0.00755	CbGeAlD
Cimetidine—Renal failure—Docetaxel—ovarian cancer	0.000338	0.00271	CcSEcCtD
Cimetidine—Hepatic failure—Epirubicin—ovarian cancer	0.000335	0.00269	CcSEcCtD
Cimetidine—CYP2C8—testis—ovarian cancer	0.000334	0.00746	CbGeAlD
Cimetidine—Fatigue—Vinorelbine—ovarian cancer	0.000332	0.00266	CcSEcCtD
Cimetidine—Hypersensitivity—Topotecan—ovarian cancer	0.000331	0.00266	CcSEcCtD
Cimetidine—Constipation—Vinorelbine—ovarian cancer	0.000329	0.00264	CcSEcCtD
Cimetidine—ABCB1—embryo—ovarian cancer	0.000328	0.00731	CbGeAlD
Cimetidine—Hypersensitivity—Melphalan—ovarian cancer	0.000324	0.0026	CcSEcCtD
Cimetidine—Asthenia—Topotecan—ovarian cancer	0.000323	0.00259	CcSEcCtD
Cimetidine—Alopecia—Paclitaxel—ovarian cancer	0.000322	0.00258	CcSEcCtD
Cimetidine—Vomiting—Chlorambucil—ovarian cancer	0.000321	0.00258	CcSEcCtD
Cimetidine—Agranulocytosis—Docetaxel—ovarian cancer	0.000321	0.00258	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000319	0.00256	CcSEcCtD
Cimetidine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000317	0.00255	CcSEcCtD
Cimetidine—Renal impairment—Epirubicin—ovarian cancer	0.000316	0.00254	CcSEcCtD
Cimetidine—Asthenia—Melphalan—ovarian cancer	0.000316	0.00254	CcSEcCtD
Cimetidine—Flatulence—Paclitaxel—ovarian cancer	0.000312	0.00251	CcSEcCtD
Cimetidine—Hepatic failure—Doxorubicin—ovarian cancer	0.00031	0.00249	CcSEcCtD
Cimetidine—Hepatitis—Docetaxel—ovarian cancer	0.000309	0.00248	CcSEcCtD
Cimetidine—Diarrhoea—Topotecan—ovarian cancer	0.000308	0.00247	CcSEcCtD
Cimetidine—Body temperature increased—Vinorelbine—ovarian cancer	0.000304	0.00244	CcSEcCtD
Cimetidine—Diarrhoea—Melphalan—ovarian cancer	0.000301	0.00242	CcSEcCtD
Cimetidine—Nausea—Chlorambucil—ovarian cancer	0.0003	0.00241	CcSEcCtD
Cimetidine—Dizziness—Topotecan—ovarian cancer	0.000297	0.00239	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000295	0.00237	CcSEcCtD
Cimetidine—Renal impairment—Doxorubicin—ovarian cancer	0.000293	0.00235	CcSEcCtD
Cimetidine—Erythema multiforme—Docetaxel—ovarian cancer	0.000292	0.00234	CcSEcCtD
Cimetidine—Agitation—Paclitaxel—ovarian cancer	0.000291	0.00234	CcSEcCtD
Cimetidine—Vomiting—Topotecan—ovarian cancer	0.000286	0.0023	CcSEcCtD
Cimetidine—Malaise—Paclitaxel—ovarian cancer	0.000286	0.0023	CcSEcCtD
Cimetidine—Leukopenia—Paclitaxel—ovarian cancer	0.000284	0.00228	CcSEcCtD
Cimetidine—Rash—Topotecan—ovarian cancer	0.000283	0.00228	CcSEcCtD
Cimetidine—Hypersensitivity—Vinorelbine—ovarian cancer	0.000283	0.00228	CcSEcCtD
Cimetidine—Dermatitis—Topotecan—ovarian cancer	0.000283	0.00227	CcSEcCtD
Cimetidine—Blood creatinine increased—Epirubicin—ovarian cancer	0.000282	0.00226	CcSEcCtD
Cimetidine—Headache—Topotecan—ovarian cancer	0.000282	0.00226	CcSEcCtD
Cimetidine—CYP2E1—testis—ovarian cancer	0.000282	0.00628	CbGeAlD
Cimetidine—CYP3A4—female reproductive system—ovarian cancer	0.000281	0.00626	CbGeAlD
Cimetidine—Vomiting—Melphalan—ovarian cancer	0.00028	0.00225	CcSEcCtD
Cimetidine—Rash—Melphalan—ovarian cancer	0.000278	0.00223	CcSEcCtD
Cimetidine—Dermatitis—Melphalan—ovarian cancer	0.000277	0.00223	CcSEcCtD
Cimetidine—CYP2D6—female reproductive system—ovarian cancer	0.000276	0.00616	CbGeAlD
Cimetidine—Asthenia—Vinorelbine—ovarian cancer	0.000276	0.00222	CcSEcCtD
Cimetidine—Alopecia—Docetaxel—ovarian cancer	0.000273	0.00219	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000271	0.00218	CcSEcCtD
Cimetidine—Arthralgia—Paclitaxel—ovarian cancer	0.00027	0.00217	CcSEcCtD
Cimetidine—Myalgia—Paclitaxel—ovarian cancer	0.00027	0.00217	CcSEcCtD
Cimetidine—Anxiety—Paclitaxel—ovarian cancer	0.000269	0.00216	CcSEcCtD
Cimetidine—ABCB1—epithelium—ovarian cancer	0.000267	0.00597	CbGeAlD
Cimetidine—Nausea—Topotecan—ovarian cancer	0.000267	0.00214	CcSEcCtD
Cimetidine—ABCB1—uterine cervix—ovarian cancer	0.000265	0.00592	CbGeAlD
Cimetidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000263	0.00211	CcSEcCtD
Cimetidine—Nausea—Melphalan—ovarian cancer	0.000261	0.0021	CcSEcCtD
Cimetidine—Confusional state—Paclitaxel—ovarian cancer	0.000261	0.00209	CcSEcCtD
Cimetidine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000261	0.00209	CcSEcCtD
Cimetidine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000259	0.00208	CcSEcCtD
Cimetidine—Pancreatitis—Epirubicin—ovarian cancer	0.000255	0.00205	CcSEcCtD
Cimetidine—Dizziness—Vinorelbine—ovarian cancer	0.000254	0.00204	CcSEcCtD
Cimetidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000253	0.00203	CcSEcCtD
Cimetidine—ABCB1—decidua—ovarian cancer	0.000253	0.00564	CbGeAlD
Cimetidine—Tachycardia—Paclitaxel—ovarian cancer	0.000252	0.00203	CcSEcCtD
Cimetidine—CYP2D6—female gonad—ovarian cancer	0.000251	0.00561	CbGeAlD
Cimetidine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000251	0.00201	CcSEcCtD
Cimetidine—SLC22A5—lymph node—ovarian cancer	0.00025	0.00559	CbGeAlD
Cimetidine—Pancytopenia—Epirubicin—ovarian cancer	0.000247	0.00198	CcSEcCtD
Cimetidine—Vomiting—Vinorelbine—ovarian cancer	0.000245	0.00196	CcSEcCtD
Cimetidine—Neutropenia—Epirubicin—ovarian cancer	0.000243	0.00195	CcSEcCtD
Cimetidine—Rash—Vinorelbine—ovarian cancer	0.000243	0.00195	CcSEcCtD
Cimetidine—Dermatitis—Vinorelbine—ovarian cancer	0.000242	0.00195	CcSEcCtD
Cimetidine—Headache—Vinorelbine—ovarian cancer	0.000241	0.00194	CcSEcCtD
Cimetidine—Leukopenia—Docetaxel—ovarian cancer	0.00024	0.00193	CcSEcCtD
Cimetidine—ABCB1—endometrium—ovarian cancer	0.00024	0.00535	CbGeAlD
Cimetidine—Pancreatitis—Doxorubicin—ovarian cancer	0.000236	0.00189	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000236	0.00189	CcSEcCtD
Cimetidine—Pneumonia—Epirubicin—ovarian cancer	0.000233	0.00187	CcSEcCtD
Cimetidine—Drowsiness—Epirubicin—ovarian cancer	0.000232	0.00186	CcSEcCtD
Cimetidine—Somnolence—Paclitaxel—ovarian cancer	0.00023	0.00185	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00023	0.00185	CcSEcCtD
Cimetidine—Arthralgia—Docetaxel—ovarian cancer	0.000229	0.00184	CcSEcCtD
Cimetidine—Myalgia—Docetaxel—ovarian cancer	0.000229	0.00184	CcSEcCtD
Cimetidine—Pancytopenia—Doxorubicin—ovarian cancer	0.000229	0.00184	CcSEcCtD
Cimetidine—Nausea—Vinorelbine—ovarian cancer	0.000228	0.00183	CcSEcCtD
Cimetidine—Renal failure—Epirubicin—ovarian cancer	0.000228	0.00183	CcSEcCtD
Cimetidine—Neutropenia—Doxorubicin—ovarian cancer	0.000225	0.00181	CcSEcCtD
Cimetidine—Fatigue—Paclitaxel—ovarian cancer	0.000223	0.00179	CcSEcCtD
Cimetidine—CYP2D6—testis—ovarian cancer	0.000223	0.00497	CbGeAlD
Cimetidine—ABCB1—gonad—ovarian cancer	0.000222	0.00496	CbGeAlD
Cimetidine—Constipation—Paclitaxel—ovarian cancer	0.000221	0.00178	CcSEcCtD
Cimetidine—Confusional state—Docetaxel—ovarian cancer	0.000221	0.00178	CcSEcCtD
Cimetidine—ABCB1—uterus—ovarian cancer	0.000221	0.00493	CbGeAlD
Cimetidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000219	0.00176	CcSEcCtD
Cimetidine—Agranulocytosis—Epirubicin—ovarian cancer	0.000216	0.00174	CcSEcCtD
Cimetidine—Pneumonia—Doxorubicin—ovarian cancer	0.000216	0.00173	CcSEcCtD
Cimetidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000215	0.00172	CcSEcCtD
Cimetidine—Drowsiness—Doxorubicin—ovarian cancer	0.000215	0.00172	CcSEcCtD
Cimetidine—Tachycardia—Docetaxel—ovarian cancer	0.000214	0.00172	CcSEcCtD
Cimetidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000213	0.00171	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000213	0.00171	CcSEcCtD
Cimetidine—Bradycardia—Epirubicin—ovarian cancer	0.000212	0.0017	CcSEcCtD
Cimetidine—Renal failure—Doxorubicin—ovarian cancer	0.000211	0.00169	CcSEcCtD
Cimetidine—Hepatitis—Epirubicin—ovarian cancer	0.000208	0.00167	CcSEcCtD
Cimetidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000205	0.00164	CcSEcCtD
Cimetidine—Agranulocytosis—Doxorubicin—ovarian cancer	0.0002	0.00161	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.0002	0.0016	CcSEcCtD
Cimetidine—ABCB1—female reproductive system—ovarian cancer	0.000199	0.00443	CbGeAlD
Cimetidine—Erythema multiforme—Epirubicin—ovarian cancer	0.000197	0.00158	CcSEcCtD
Cimetidine—Bradycardia—Doxorubicin—ovarian cancer	0.000196	0.00157	CcSEcCtD
Cimetidine—Somnolence—Docetaxel—ovarian cancer	0.000195	0.00157	CcSEcCtD
Cimetidine—Hepatitis—Doxorubicin—ovarian cancer	0.000193	0.00155	CcSEcCtD
Cimetidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000191	0.00153	CcSEcCtD
Cimetidine—Fatigue—Docetaxel—ovarian cancer	0.000189	0.00152	CcSEcCtD
Cimetidine—ABCB1—bone marrow—ovarian cancer	0.000188	0.00418	CbGeAlD
Cimetidine—Constipation—Docetaxel—ovarian cancer	0.000188	0.00151	CcSEcCtD
Cimetidine—Asthenia—Paclitaxel—ovarian cancer	0.000186	0.00149	CcSEcCtD
Cimetidine—Alopecia—Epirubicin—ovarian cancer	0.000184	0.00148	CcSEcCtD
Cimetidine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000182	0.00146	CcSEcCtD
Cimetidine—ABCB1—female gonad—ovarian cancer	0.000181	0.00403	CbGeAlD
Cimetidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000181	0.00145	CcSEcCtD
Cimetidine—ABCB1—vagina—ovarian cancer	0.00018	0.00401	CbGeAlD
Cimetidine—Flatulence—Epirubicin—ovarian cancer	0.000179	0.00143	CcSEcCtD
Cimetidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000177	0.00142	CcSEcCtD
Cimetidine—Body temperature increased—Docetaxel—ovarian cancer	0.000173	0.00139	CcSEcCtD
Cimetidine—Dizziness—Paclitaxel—ovarian cancer	0.000171	0.00137	CcSEcCtD
Cimetidine—Alopecia—Doxorubicin—ovarian cancer	0.00017	0.00137	CcSEcCtD
Cimetidine—Agitation—Epirubicin—ovarian cancer	0.000167	0.00134	CcSEcCtD
Cimetidine—Flatulence—Doxorubicin—ovarian cancer	0.000165	0.00133	CcSEcCtD
Cimetidine—Vomiting—Paclitaxel—ovarian cancer	0.000164	0.00132	CcSEcCtD
Cimetidine—Malaise—Epirubicin—ovarian cancer	0.000163	0.00131	CcSEcCtD
Cimetidine—Rash—Paclitaxel—ovarian cancer	0.000163	0.00131	CcSEcCtD
Cimetidine—Dermatitis—Paclitaxel—ovarian cancer	0.000163	0.00131	CcSEcCtD
Cimetidine—Leukopenia—Epirubicin—ovarian cancer	0.000162	0.0013	CcSEcCtD
Cimetidine—Headache—Paclitaxel—ovarian cancer	0.000162	0.0013	CcSEcCtD
Cimetidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000162	0.0013	CcSEcCtD
Cimetidine—ABCB1—testis—ovarian cancer	0.00016	0.00358	CbGeAlD
Cimetidine—Asthenia—Docetaxel—ovarian cancer	0.000157	0.00126	CcSEcCtD
Cimetidine—Myalgia—Epirubicin—ovarian cancer	0.000154	0.00124	CcSEcCtD
Cimetidine—Arthralgia—Epirubicin—ovarian cancer	0.000154	0.00124	CcSEcCtD
Cimetidine—Agitation—Doxorubicin—ovarian cancer	0.000154	0.00124	CcSEcCtD
Cimetidine—Anxiety—Epirubicin—ovarian cancer	0.000154	0.00123	CcSEcCtD
Cimetidine—Nausea—Paclitaxel—ovarian cancer	0.000154	0.00123	CcSEcCtD
Cimetidine—Malaise—Doxorubicin—ovarian cancer	0.000151	0.00121	CcSEcCtD
Cimetidine—Leukopenia—Doxorubicin—ovarian cancer	0.00015	0.00121	CcSEcCtD
Cimetidine—Diarrhoea—Docetaxel—ovarian cancer	0.00015	0.0012	CcSEcCtD
Cimetidine—Confusional state—Epirubicin—ovarian cancer	0.000149	0.0012	CcSEcCtD
Cimetidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000148	0.00119	CcSEcCtD
Cimetidine—Dizziness—Docetaxel—ovarian cancer	0.000145	0.00116	CcSEcCtD
Cimetidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000145	0.00116	CcSEcCtD
Cimetidine—Tachycardia—Epirubicin—ovarian cancer	0.000144	0.00116	CcSEcCtD
Cimetidine—Myalgia—Doxorubicin—ovarian cancer	0.000143	0.00115	CcSEcCtD
Cimetidine—Arthralgia—Doxorubicin—ovarian cancer	0.000143	0.00115	CcSEcCtD
Cimetidine—Anxiety—Doxorubicin—ovarian cancer	0.000142	0.00114	CcSEcCtD
Cimetidine—Vomiting—Docetaxel—ovarian cancer	0.000139	0.00112	CcSEcCtD
Cimetidine—Rash—Docetaxel—ovarian cancer	0.000138	0.00111	CcSEcCtD
Cimetidine—Dermatitis—Docetaxel—ovarian cancer	0.000138	0.00111	CcSEcCtD
Cimetidine—Confusional state—Doxorubicin—ovarian cancer	0.000138	0.00111	CcSEcCtD
Cimetidine—Headache—Docetaxel—ovarian cancer	0.000137	0.0011	CcSEcCtD
Cimetidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000137	0.0011	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000135	0.00108	CcSEcCtD
Cimetidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000134	0.00108	CcSEcCtD
Cimetidine—Tachycardia—Doxorubicin—ovarian cancer	0.000134	0.00107	CcSEcCtD
Cimetidine—Somnolence—Epirubicin—ovarian cancer	0.000131	0.00106	CcSEcCtD
Cimetidine—Nausea—Docetaxel—ovarian cancer	0.00013	0.00105	CcSEcCtD
Cimetidine—Fatigue—Epirubicin—ovarian cancer	0.000128	0.00102	CcSEcCtD
Cimetidine—Constipation—Epirubicin—ovarian cancer	0.000126	0.00102	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000125	0.001	CcSEcCtD
Cimetidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000122	0.000979	CcSEcCtD
Cimetidine—Somnolence—Doxorubicin—ovarian cancer	0.000122	0.000977	CcSEcCtD
Cimetidine—Fatigue—Doxorubicin—ovarian cancer	0.000118	0.000948	CcSEcCtD
Cimetidine—Constipation—Doxorubicin—ovarian cancer	0.000117	0.00094	CcSEcCtD
Cimetidine—Body temperature increased—Epirubicin—ovarian cancer	0.000117	0.000939	CcSEcCtD
Cimetidine—ABCB1—lymph node—ovarian cancer	0.000116	0.00259	CbGeAlD
Cimetidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000113	0.000906	CcSEcCtD
Cimetidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000109	0.000875	CcSEcCtD
Cimetidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000108	0.000869	CcSEcCtD
Cimetidine—Asthenia—Epirubicin—ovarian cancer	0.000106	0.000852	CcSEcCtD
Cimetidine—Diarrhoea—Epirubicin—ovarian cancer	0.000101	0.000813	CcSEcCtD
Cimetidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000101	0.00081	CcSEcCtD
Cimetidine—Asthenia—Doxorubicin—ovarian cancer	9.82e-05	0.000789	CcSEcCtD
Cimetidine—Dizziness—Epirubicin—ovarian cancer	9.78e-05	0.000785	CcSEcCtD
Cimetidine—Vomiting—Epirubicin—ovarian cancer	9.4e-05	0.000755	CcSEcCtD
Cimetidine—Diarrhoea—Doxorubicin—ovarian cancer	9.36e-05	0.000752	CcSEcCtD
Cimetidine—Rash—Epirubicin—ovarian cancer	9.33e-05	0.000749	CcSEcCtD
Cimetidine—Dermatitis—Epirubicin—ovarian cancer	9.32e-05	0.000748	CcSEcCtD
Cimetidine—Headache—Epirubicin—ovarian cancer	9.27e-05	0.000744	CcSEcCtD
Cimetidine—Dizziness—Doxorubicin—ovarian cancer	9.05e-05	0.000727	CcSEcCtD
Cimetidine—Nausea—Epirubicin—ovarian cancer	8.78e-05	0.000706	CcSEcCtD
Cimetidine—Vomiting—Doxorubicin—ovarian cancer	8.7e-05	0.000699	CcSEcCtD
Cimetidine—Rash—Doxorubicin—ovarian cancer	8.63e-05	0.000693	CcSEcCtD
Cimetidine—Dermatitis—Doxorubicin—ovarian cancer	8.62e-05	0.000692	CcSEcCtD
Cimetidine—Headache—Doxorubicin—ovarian cancer	8.57e-05	0.000688	CcSEcCtD
Cimetidine—Nausea—Doxorubicin—ovarian cancer	8.13e-05	0.000653	CcSEcCtD
Cimetidine—HRH2—Signaling Pathways—IL6ST—ovarian cancer	8.8e-06	0.000256	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CG—ovarian cancer	8.73e-06	0.000254	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	8.54e-06	0.000248	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	8.53e-06	0.000248	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	8.53e-06	0.000248	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—APC—ovarian cancer	8.45e-06	0.000246	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CG—ovarian cancer	8.45e-06	0.000246	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—NRAS—ovarian cancer	8.45e-06	0.000246	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—BRIP1—ovarian cancer	8.42e-06	0.000245	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	8.42e-06	0.000245	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—YAP1—ovarian cancer	8.12e-06	0.000236	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—MAPK3—ovarian cancer	8.1e-06	0.000235	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.04e-06	0.000234	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PIK3CD—ovarian cancer	8e-06	0.000233	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	7.95e-06	0.000231	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ABCB1—ovarian cancer	7.93e-06	0.000231	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ABCB1—ovarian cancer	7.92e-06	0.00023	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.88e-06	0.000229	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.83e-06	0.000228	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—TYMS—ovarian cancer	7.79e-06	0.000226	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—TYMS—ovarian cancer	7.78e-06	0.000226	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—MAPK1—ovarian cancer	7.7e-06	0.000224	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—EGFR—ovarian cancer	7.7e-06	0.000224	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PTEN—ovarian cancer	7.69e-06	0.000224	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CD—ovarian cancer	7.67e-06	0.000223	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—FASN—ovarian cancer	7.66e-06	0.000223	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—FASN—ovarian cancer	7.65e-06	0.000222	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.58e-06	0.00022	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—AKT1—ovarian cancer	7.54e-06	0.000219	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	7.54e-06	0.000219	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—SLC5A5—ovarian cancer	7.52e-06	0.000219	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYTB—ovarian cancer	7.44e-06	0.000216	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CD—ovarian cancer	7.43e-06	0.000216	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ABCB1—ovarian cancer	7.38e-06	0.000215	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—PIK3CA—ovarian cancer	7.36e-06	0.000214	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	7.28e-06	0.000212	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—KRAS—ovarian cancer	7.27e-06	0.000211	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	7.26e-06	0.000211	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—YAP1—ovarian cancer	7.25e-06	0.000211	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—TYMS—ovarian cancer	7.25e-06	0.000211	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.18e-06	0.000209	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.18e-06	0.000209	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—YAP1—ovarian cancer	7.08e-06	0.000206	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.07e-06	0.000205	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	6.98e-06	0.000203	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PIK3CB—ovarian cancer	6.98e-06	0.000203	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	6.96e-06	0.000202	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CB—ovarian cancer	6.69e-06	0.000194	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—PIK3CA—ovarian cancer	6.68e-06	0.000194	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—YAP1—ovarian cancer	6.67e-06	0.000194	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—FASN—ovarian cancer	6.62e-06	0.000192	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—YAP1—ovarian cancer	6.61e-06	0.000192	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PIK3CA—ovarian cancer	6.6e-06	0.000192	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ERBB2—ovarian cancer	6.56e-06	0.000191	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.54e-06	0.00019	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	6.51e-06	0.000189	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.5e-06	0.000189	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.5e-06	0.000189	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MTOR—ovarian cancer	6.48e-06	0.000188	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CB—ovarian cancer	6.48e-06	0.000188	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.4e-06	0.000186	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.31e-06	0.000183	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	6.29e-06	0.000183	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CAV1—ovarian cancer	6.28e-06	0.000182	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CAV1—ovarian cancer	6.27e-06	0.000182	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CXCL8—ovarian cancer	6.22e-06	0.000181	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	6.19e-06	0.00018	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—HRAS—ovarian cancer	6.18e-06	0.00018	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	6.18e-06	0.000179	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.16e-06	0.000179	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.14e-06	0.000178	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CDKN1B—ovarian cancer	6.08e-06	0.000177	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	6.03e-06	0.000175	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTEN—ovarian cancer	6.03e-06	0.000175	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—AKT1—ovarian cancer	6.01e-06	0.000175	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CASP3—ovarian cancer	5.96e-06	0.000173	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL2—ovarian cancer	5.95e-06	0.000173	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL6—ovarian cancer	5.92e-06	0.000172	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—FASN—ovarian cancer	5.91e-06	0.000172	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CAV1—ovarian cancer	5.84e-06	0.00017	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.81e-06	0.000169	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCND1—ovarian cancer	5.8e-06	0.000169	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTEN—ovarian cancer	5.78e-06	0.000168	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—FASN—ovarian cancer	5.77e-06	0.000168	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.75e-06	0.000167	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ABCB1—ovarian cancer	5.75e-06	0.000167	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CTNNB1—ovarian cancer	5.74e-06	0.000167	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ABCB1—ovarian cancer	5.73e-06	0.000167	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	5.72e-06	0.000166	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	5.71e-06	0.000166	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.67e-06	0.000165	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—YAP1—ovarian cancer	5.65e-06	0.000164	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—TYMS—ovarian cancer	5.64e-06	0.000164	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—TYMS—ovarian cancer	5.63e-06	0.000164	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MMP9—ovarian cancer	5.63e-06	0.000164	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.62e-06	0.000163	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTEN—ovarian cancer	5.6e-06	0.000163	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.59e-06	0.000163	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.5e-06	0.00016	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.48e-06	0.000159	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—AKT1—ovarian cancer	5.46e-06	0.000159	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—FASN—ovarian cancer	5.44e-06	0.000158	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PIK3CA—ovarian cancer	5.43e-06	0.000158	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—AKT1—ovarian cancer	5.39e-06	0.000157	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—FASN—ovarian cancer	5.39e-06	0.000157	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	5.38e-06	0.000156	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.35e-06	0.000155	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.35e-06	0.000155	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.32e-06	0.000155	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CG—ovarian cancer	5.32e-06	0.000155	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.3e-06	0.000154	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.25e-06	0.000153	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	5.16e-06	0.00015	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.12e-06	0.000149	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—VEGFA—ovarian cancer	5.06e-06	0.000147	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	5.03e-06	0.000146	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	5.02e-06	0.000146	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.01e-06	0.000146	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STAT3—ovarian cancer	5.01e-06	0.000145	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NRAS—ovarian cancer	4.99e-06	0.000145	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.97e-06	0.000144	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.95e-06	0.000144	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.92e-06	0.000143	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.91e-06	0.000143	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—TYMS—ovarian cancer	4.88e-06	0.000142	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MAPK3—ovarian cancer	4.78e-06	0.000139	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.77e-06	0.000139	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.75e-06	0.000138	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CD—ovarian cancer	4.68e-06	0.000136	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.66e-06	0.000135	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MYC—ovarian cancer	4.65e-06	0.000135	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—FASN—ovarian cancer	4.61e-06	0.000134	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MAPK1—ovarian cancer	4.55e-06	0.000132	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—EGFR—ovarian cancer	4.55e-06	0.000132	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CAV1—ovarian cancer	4.55e-06	0.000132	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CAV1—ovarian cancer	4.54e-06	0.000132	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.53e-06	0.000132	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—AKT1—ovarian cancer	4.43e-06	0.000129	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.43e-06	0.000129	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.39e-06	0.000128	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	4.38e-06	0.000127	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.38e-06	0.000127	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	4.37e-06	0.000127	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—YAP1—ovarian cancer	4.36e-06	0.000127	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—TYMS—ovarian cancer	4.35e-06	0.000127	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.35e-06	0.000127	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.33e-06	0.000126	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KRAS—ovarian cancer	4.3e-06	0.000125	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.28e-06	0.000125	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PIK3CA—ovarian cancer	4.25e-06	0.000124	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—TYMS—ovarian cancer	4.25e-06	0.000124	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.19e-06	0.000122	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	4.14e-06	0.00012	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.13e-06	0.00012	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CB—ovarian cancer	4.08e-06	0.000119	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.08e-06	0.000119	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CA—ovarian cancer	4.08e-06	0.000118	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.04e-06	0.000117	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—TYMS—ovarian cancer	4e-06	0.000116	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—TYMS—ovarian cancer	3.97e-06	0.000115	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CA—ovarian cancer	3.95e-06	0.000115	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CAV1—ovarian cancer	3.93e-06	0.000114	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—ovarian cancer	3.82e-06	0.000111	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTEN—ovarian cancer	3.79e-06	0.00011	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTEN—ovarian cancer	3.78e-06	0.00011	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.76e-06	0.000109	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.72e-06	0.000108	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.7e-06	0.000108	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HRAS—ovarian cancer	3.65e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.64e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.63e-06	0.000106	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.58e-06	0.000104	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—FASN—ovarian cancer	3.55e-06	0.000103	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTEN—ovarian cancer	3.52e-06	0.000102	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CAV1—ovarian cancer	3.51e-06	0.000102	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL6—ovarian cancer	3.5e-06	0.000102	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.5e-06	0.000102	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—AKT1—ovarian cancer	3.47e-06	0.000101	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.45e-06	0.0001	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CAV1—ovarian cancer	3.42e-06	9.95e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.39e-06	9.86e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.38e-06	9.81e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.35e-06	9.74e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—AKT1—ovarian cancer	3.33e-06	9.68e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.24e-06	9.41e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.23e-06	9.38e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—AKT1—ovarian cancer	3.23e-06	9.37e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CAV1—ovarian cancer	3.2e-06	9.3e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.2e-06	9.29e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	3.17e-06	9.22e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.17e-06	9.21e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.15e-06	9.15e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.12e-06	9.07e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.06e-06	8.88e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.94e-06	8.54e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.91e-06	8.47e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.87e-06	8.34e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.81e-06	8.17e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.74e-06	7.97e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTEN—ovarian cancer	2.74e-06	7.97e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.74e-06	7.97e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTEN—ovarian cancer	2.74e-06	7.95e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CAV1—ovarian cancer	2.73e-06	7.95e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.67e-06	7.76e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	2.67e-06	7.75e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.67e-06	7.75e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.62e-06	7.61e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.61e-06	7.59e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.58e-06	7.51e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.56e-06	7.45e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.49e-06	7.24e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	2.49e-06	7.22e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.45e-06	7.12e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.39e-06	6.95e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTEN—ovarian cancer	2.37e-06	6.89e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.25e-06	6.55e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.23e-06	6.49e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.19e-06	6.36e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—AKT1—ovarian cancer	2.18e-06	6.34e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—AKT1—ovarian cancer	2.18e-06	6.33e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTEN—ovarian cancer	2.12e-06	6.15e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.11e-06	6.13e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTEN—ovarian cancer	2.07e-06	6e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—AKT1—ovarian cancer	2.03e-06	5.9e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTEN—ovarian cancer	1.95e-06	5.66e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.93e-06	5.62e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.93e-06	5.61e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTEN—ovarian cancer	1.93e-06	5.61e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.92e-06	5.59e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.91e-06	5.55e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.69e-06	4.91e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.67e-06	4.86e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.65e-06	4.79e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—AKT1—ovarian cancer	1.58e-06	4.59e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—AKT1—ovarian cancer	1.58e-06	4.58e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.49e-06	4.34e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.47e-06	4.28e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.46e-06	4.23e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.37e-06	3.99e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.37e-06	3.97e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.36e-06	3.96e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.27e-06	3.7e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—AKT1—ovarian cancer	1.22e-06	3.54e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—AKT1—ovarian cancer	1.19e-06	3.46e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.16e-06	3.38e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.12e-06	3.26e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.11e-06	3.23e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—AKT1—ovarian cancer	9.5e-07	2.76e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.98e-07	2.61e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—AKT1—ovarian cancer	7.33e-07	2.13e-05	CbGpPWpGaD
